PRESS RELEASE published on 01/24/2024 at 14:00, 2 years 8 months ago AiCuris and the German Center for Infection Research (DZIF) sign Collaboration and License Option Agreement AiCuris and the German Center for Infection Research (DZIF) have signed a collaboration and license option agreement to discover new active agents for the treatment and prophylaxis of infections of immunocompromised patients. The partnership aims to develop novel therapies for patients with high medical need. The financial details of the collaboration were not disclosed. For more information, visit www.dzif.de and www.aicuris.com. AiCuris German Center For Infection Research Collaboration License Option Agreement Immunocompromised Patients
PRESS RELEASE published on 09/28/2023 at 14:00, 3 years ago AiCuris´ AiCubator Program Opens New Application Round for Innovative Projects with Focus on Treatment Options for Viral Infections in Immunocompromised Patients
PRESS RELEASE published on 08/23/2023 at 14:00, 3 years 1 month ago AiCuris Received 30 Million Euros Milestone Payment from Licensing Partner MSD Following U.S. FDA Approval of PREVYMIS® (letermovir) in Second Indication
PRESS RELEASE published on 07/06/2023 at 14:00, 3 years 3 months ago AiCuris Announces Strategic Shift to Focus Development and Commercialization of Anti-infectives for Immunocompromised Patients
PRESS RELEASE published on 04/04/2023 at 14:00, 3 years 6 months ago AiCuris AG Announces Appointment of Larry Edwards as Chief Executive Officer and Formation of U.S. Subsidiary
Published on 10/13/2026 at 15:00, 19 minutes ago Reminder: Today, October 13, 2026, is the Record Date for Jaguar Health's Special Stock Dividend
Published on 10/13/2026 at 14:45, 34 minutes ago Phase II Clinical Trial of NV-387 Oral Gummies as Treatment of Ebola Progressing Well, Says NanoViricides
Published on 10/13/2026 at 14:31, 48 minutes ago First Breach Completes First Autonomous Flight of Proprietary Drone Prototype
Published on 10/13/2026 at 14:10, 1 hour 9 minutes ago NioCorp Places 100% of Its Planned Critical Minerals Production Under Commercial Sales Agreements
Published on 10/13/2026 at 14:00, 1 hour 19 minutes ago Orogen Royalties Enters into Agreement to Sell the Slaughterhouse Copper-Gold Project to Seabridge Gold
Published on 10/13/2026 at 15:05, 13 minutes ago Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
Published on 10/13/2026 at 15:05, 13 minutes ago Graylog v7.2 launches the Verascend™ Incident System, transforming how security teams detect and respond to threats
Published on 10/13/2026 at 15:03, 15 minutes ago Form 8.3 - The Vanguard Group, Inc.: Permanent TSB Group Holdings plc
Published on 10/13/2026 at 09:04, 6 hours 14 minutes ago Peru Is Recognized as “South America's Leading Destination” at the World Travel Awards
Published on 10/12/2026 at 17:59, 21 hours 19 minutes ago Reporting on share buyback transactions carried out between October 7 and October 9, 2026
Published on 10/12/2026 at 17:45, 21 hours 34 minutes ago Declaration of transactions on own shares from October 5, 2026 to October 11, 2026
Published on 10/12/2026 at 15:47, 23 hours 31 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of September 30, 2026
